Back

Sodium glucose co-transporter 2 inhibition prevents muscle energy metabolism changes in infarcted rats

27 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Chronic heart failure - Bench studies Peripheral Circulation, Metabolism, Skeletal Muscle ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Lidiane Moreira Souza

Botucatu (Brazil)

5 More presentations in this session

Presentation thumbnail
Target induction of heme oxygenase-1 attenuates anti-HLA I antibody induced transplant vasculopathy in an allogeneic aortic transplantation model in mice
Doctor L. Kummer (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
Nitro-oxidative stress impairs single cardiomyocyte adrenergic reserve in a murine model of HFpEF.
Mr L. Semmler (Berlin, DE)
Abstract Slides
Presentation thumbnail
Deletion of the extracellular matrix glycoprotein ADAMTSL3 increases pro-fibrotic signalling and exacerbates heart failure in mice
Doctor K. Rypdal (Oslo, NO)
Abstract Slides
Presentation thumbnail
Treatment with activin type ii receptor antibody improves cardiac function in mice after myocardial infarction
Doctor W. Bao (Gaithersburg, US)
Abstract Slides
Presentation thumbnail
Takotsubo syndrome-like model in rats with high reproducibility and low mortality
Doctor E. Zulfaj (Gothenburg, SE)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - Bench studies

The Event

Event poster

ESC Congress 2022

27 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Influence of long-term sodium-glucose cotransporter 2 inhibition on cardiac remodeling in rats with type 1 diabetes mellitus
27 August 2022
thumbnail
Congress Presentation
Multilevel metabolic impairments in skeletal muscle of heart failure patients
29 June 2021
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors on temporal change of skeletal muscle index in patients with outpatient cardiac rehabilitation program
3 April 2025
thumbnail
Congress Presentation
Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources